Roivant Sciences Ltd. (ROIV)
22.09
+0.75
(+3.51%)
USD |
NASDAQ |
Dec 12, 16:00
22.23
+0.14
(+0.63%)
After-Hours: 20:00
Roivant Sciences Total Assets (Quarterly): 5.063B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 114.46B |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 43.50M |
| Autolus Therapeutics Plc | 661.95M |
| Tiziana Life Sciences Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 257.14M |
| Shareholders Equity (Quarterly) | 4.362B |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 33.70 |
| Net Debt Paydown Yield | 0.54% |